Abstract
Protein glycosylation represents one of the most important post-translational events, and is a mean of diversifying a protein without recourse to the genome. The venoms produced by snakes contain an abundance of glycoproteins with N-linked carbohydrates. N-linked glycosylation can ensure the correct folding of important functional domains. Characterization of carbohydrates structures aids in development of human therapeutics by snake venom toxins.
Keywords: N-linked oligosaccharides, snake venom, enzyme activity, serine protease
Protein & Peptide Letters
Title: Venom-Sweet-Venom: N-Linked Glycosylation in Snake Venom Toxins
Volume: 16 Issue: 8
Author(s): Sandro G. Soares and Leandro L. Oliveira
Affiliation:
Keywords: N-linked oligosaccharides, snake venom, enzyme activity, serine protease
Abstract: Protein glycosylation represents one of the most important post-translational events, and is a mean of diversifying a protein without recourse to the genome. The venoms produced by snakes contain an abundance of glycoproteins with N-linked carbohydrates. N-linked glycosylation can ensure the correct folding of important functional domains. Characterization of carbohydrates structures aids in development of human therapeutics by snake venom toxins.
Export Options
About this article
Cite this article as:
Soares G. Sandro and Oliveira L. Leandro, Venom-Sweet-Venom: N-Linked Glycosylation in Snake Venom Toxins, Protein & Peptide Letters 2009; 16 (8) . https://dx.doi.org/10.2174/092986609788923293
DOI https://dx.doi.org/10.2174/092986609788923293 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Thoracic Surgical Approaches in the Trauma Setting: A Basic Review
Current Respiratory Medicine Reviews Applications of Nanosystems to Anticancer Drug Therapy (Part II. Dendrimers, Micelles, Lipid-based Nanosystems)
Recent Patents on Anti-Cancer Drug Discovery Drotrecogin Alfa (Activated) in the Treatment of Severe Sepsis
Current Drug Safety Fatty Acid Amide Hydrolase: A Potential Target for Next Generation Therapeutics
Current Pharmaceutical Design Data-driven Approach to Detect and Predict Adverse Drug Reactions
Current Pharmaceutical Design Clinical Significance of the Blood Pressure Changes from Day to Night
Current Hypertension Reviews Enkephalinase Inhibitors: Potential Agents for the Management of Pain
Current Drug Targets Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder
Current Neuropharmacology Liposomal-All-trans-Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia
Current Cancer Therapy Reviews α-Fibrinogenases
Current Drug Targets - Cardiovascular & Hematological Disorders Medication-Induced Nephrotoxicity in Older Patients
Current Drug Metabolism Carotid Artery Stenting for the Prevention of Thromboembolic Stroke
Vascular Disease Prevention (Discontinued) Cardiovascular Side Effects of New Antidepressants and Antipsychotics: New Drugs, old Concerns?
Current Pharmaceutical Design Matrix Metalloproteinases as Drug Targets in Acute Pulmonary Embolism
Current Drug Targets Radiation-Induced Extracranial Carotid Stenosis
Vascular Disease Prevention (Discontinued) ESVS Guidelines: Section B - Diagnosis and Investigation of Patients with Carotid Stenosis
Current Vascular Pharmacology Nitric Oxide Signaling and the Cross Talk with Prostanoids Pathways in Vascular System
Medicinal Chemistry Inhalational Anesthetics in Acute Severe Asthma
Current Drug Targets Pharmacological and Non Pharmacological Strategies in the Management of Coronary Artery Disease and Chronic Kidney Disease
Current Cardiology Reviews Psychotropic Medications and the Treatment of Human Prion Diseases
CNS & Neurological Disorders - Drug Targets